Julie Boerner
Position Title
Associate Professor
Basic Science
Office Location
Karmanos Cancer Institute
Hudson-Webber Cancer Research Center - 816
4100 John R.
Detroit, MI 48201
Mailing Address
Karmanos Cancer Institute
4100 John R, HW08AO
Detroit, MI 48201
Office Phone
313-576-8351Education Training
Education
(2000) Ph.D Tumor Biology, Mayo Clinic, Rochester, MN
(1996) M.S. Endocrinology-Reproductive Physiology, University of Wisconsin, Madison, WI
(1993) B.Sc. Molecular Biology, University of Wisconsin, Madison, WI
Postgraduate Training
(2000-2005) Postdoctoral Fellowship, Department of Microbiology, University of Virginia, Charlottesville, VA
Professional Experience
Faculty Appointments
(2016-Present) Associate Professor, Department of Oncology, Wayne State University, Detroit, MI
(2010-2016) Assistant Professor, Department of Oncology, Wayne State University, Detroit, MI
(2008-Present) Graduate Faculty Member, Cancer Biology Program, Wayne State University School of Medicine, Detroit, MI
(2005-2012) Assistant Professor, Joint Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI
(2005-2010) Assistant Professor, Wayne State University School of Medicine, Detroit, MI
Hospital and Other Professional Appointments
(2013-Present) Director, Biobanking and Correlative Sciences Core, Karmanos Cancer Institute, Detroit, MI
(2012-Present) Scientific Member, Molecular Therapeutics Program, Karmanos Cancer Institute, Detroit, MI
(2008-2012) Scientific Member, Breast Cancer Biology Program, Karmanos Cancer Institute, Detroit, MI
(2005-2008) Member, Breast Cancer Biology Program, Karmanos Cancer Institute, Detroit, MI
Major Professional Societies
American Association for the Advancement of Science
American Association for Cancer Research
Women in Cancer Research
Honors and Awards
(2015) School of Medicine College Teaching Award, Department of Oncology, Wayne State University, Detroit, MI
(2011) School of Medicine College Teaching Award, Department of Oncology, Wayne State University, Detroit, MI
(2002-2003) AACR Scholar-in-Training Award, Travel award to attend the annual meeting for the American Association for Cancer Research in San Francisco, CA and Washington, D.C., respectively
(1999)Brigid Leventhol Scholar, Travel award to attend the annual meeting for the American Association for Cancer Research in Philadelphia, PA
Research Interests
My laboratory is interested in identifying novel therapeutic strategies for the treatment of triple-negative breast cancer. Triple-negative breast cancer lacks hormone receptors and HER2, thereby abrogating the use of tamoxifen or Herceptin. One molecule highly expressed in triple-negative breast cancer is epidermal growth factor receptor (EGFR). However, breast cancer do not respond to EGFR inhibitors in the clinic. Therefore, we have been studying the mechanisms of EGFR kinase-independent signaling in breast cancers and the role it plays in de novo resistance to EGFR inhibitors. Specifically, we are interested in identifying crosstalk between EGFR and other tyrosine kinases that mediate EGFR kinase-independent signaling.
Publications
Julie L. Boerner, PhD - PubMed